Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients

Acta Anaesthesiologica Scandinavica

Volumn 46, Issue 4, 2002, Pages 364-371

  Pühringer, Friedrich K ^a   Heier, T ^a   Dodgson, M ^a   Erkola, O ^a   Goonetilleke, P ^a   Hofmockel, R ^a   Gaetke, M R ^a   Mortensen, C R ^a   Upadhyaya, B ^a   Ericksson, L I ^a  

^a Klin Anaesth/Oper Intensivmed   (Germany)

Author keywords

Age; Cisatracurium; Predictability; Recovery; Variability; Vecuronium

Indexed keywords

CISATRACURIUM; PROPOFOL; VECURONIUM;

ADULT; AGE DISTRIBUTION; AGED; AGING; ANESTHESIA INDUCTION; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EVOKED RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA RECOVERY PERIOD; ATRACURIUM; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MUSCLE CONTRACTION; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREANESTHETIC MEDICATION; VECURONIUM BROMIDE;

EID: 0036241141     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2002.460406.x     Document Type: Article

References (13)

1. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia
2. The cardiovascular and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
3. Importance of the organ-independent elimination of cisatracurium
4. A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex) and vecuronium in patients with coronary artery disease
5. Distribution, elimination, and action of vecuronium in the elderly
6. Onset and duration of action of vecuronium in the elderly: Comparison with adults
7. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients
8. Onset of action of relaxants
9. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
10. Elimination of atracurium in humans. Contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination
11. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients
12. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia